IP Library Granted Patent US 10,053,719
Granted Patent B2
US 10,053,719 · App. 14/765,978 · Granted Aug 21, 2018

Compositions and methods for synthesis of high fidelity oligonucleotides

Inventors: Ishtiaq E. Saaem (Dhaka, BD); Michael E. Hudson (Framingham, MA); Stephen F. Archer (Cambridge, MA); Sophea Sann-Rorth (Revere, MA); Ellen J. Sanchez (North Andover, MA); Joseph Jacobson (Newton, MA)
Assignee: Gen9, Inc.
C12P19/34C12N15/10C12N15/1031C12N15/66
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,053,719
App. No.
14/765,978
Granted
Aug 21, 2018
Kind
B2
Abstract

Aspects of the invention relate to methods, compositions for synthesizing high fidelity oligonucleotides.

Claims (22)

1. A method for synthesizing high fidelity target oligonucleotides, the method comprising:

a. providing an array comprising a plurality of nucleic acids, each nucleic acid having a sequence comprising a template oligonucleotide sequence and a primer binding sequence, wherein the template oligonucleotide sequence is a reverse complement of the target oligonucleotide;

b. releasing the plurality of nucleic acids from the array;

c. circularizing the plurality of nucleic acids;

d. providing a primer, wherein the primer comprises a sequence complementary to the primer binding sequence, a restriction enzyme recognition site and self-complementary termini, under conditions promoting annealing of the primer to the primer binding sites;

e. amplifying the circularized nucleic acids in a rolling-circle amplification reaction using the primer, thereby forming single-stranded tandem nucleic acid sequences;

f. promoting hairpin formation of the primer wherein the restriction enzyme recognition site is formed within a double-stranded portion of the hairpin;

g. removing the primer binding sequences of the single-stranded tandem nucleic acid sequences by enzymatic cleavage using a suitable restriction enzyme; and

h. isolating the target oligonucleotides.

2. The method of claim 1 wherein in the step of releasing the plurality of nucleic acids is released in a pool.

3. The method according to claim 1 wherein the plurality of nucleic acids is immobilized on the array by their 3′ terminus.

4. The method according to claim 1 wherein the plurality of nucleic acids is synthesized on the array in a 3′-5′ direction.

5. The method according to claim 1 wherein the plurality of nucleic acids is synthesized on the array in a 5′-3′ direction.

6. The method according to claim 1 wherein the primer binding sequence is at least 100 bps long.

7. The method according to claim 1 wherein in the step of providing the array, the array comprises a plurality of template oligonucleotides and the primer binding sequence is ligated to each of the plurality of the template oligonucleotides.

8. The method according to claim 1 wherein, in the step of providing the array, the array comprises a porous reaction layer coupled to a phosphorylation reagent.

9. The method according to claim 1 wherein the primer binding site is 3′ or 5′ of the template oligonucleotide sequence.

10. The method according to claim 1 wherein the plurality of nucleic acids is phosphorylated at the 3′ end and wherein the step of releasing further comprises dephosphorylating the 3′ end of the nucleic acids and phosphorylating the 5′ end of the nucleic acids.

11. The method according to claim 1 wherein the step of circularizing is in the presence of a ligase.

12. The method according to claim 1 further comprising purifying the target oligonucleotides.

13. The method according to claim 1 wherein the primers contain dT-biotin and wherein, in the step of isolating, the oligonucleotides are purified using streptavidin beads.

14. The method of claim 1 wherein in step (a) the plurality of nucleic acids is synthesized on an array.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2025
From: GINKGO BIOWORKS, INC.
To: TWIST BIOSCIENCE CORPORATION
Reel/Frame 072092/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2025
From: GEN9, INC.
To: GINKGO BIOWORKS, INC.
Reel/Frame 071945/0972 →
CORRECTIVE ASSIGNMENT TO CORRECT THE STATE IN THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED AT REEL: 037134 FRAME: 0579. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 7, 2015
From: SAAEM, ISHTIAQ E.; HUDSON, MICHAEL E.; ARCHER, STEPHEN F.; SANN-RORTH, SOPHEA; FANTI, ELLEN J.; JACOBSON, JOSEPH
To: GEN9, INC.
Reel/Frame 037224/0201 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2015
From: SAAEM, ISHTIAQ E; HUDSON, MICHAEL E; ARCHER, STEPHEN F; SANN-RORTH, SOPHEA; FANTI, ELLEN J; JACOBSON, JOSEPH
To: GEN9, INC.
Reel/Frame 037134/0579 →
Continuity (2)
Provisional Application 61851759 · Mar 13, 2013
Related Publication 20150368687A1 · Dec 24, 2015